Navigation Links
Adenosine Therapeutics Engages Needham & Company to Explore Strategic Options for Phase III Cardiac Stress Agent
Date:4/1/2013

CHARLOTTESVILLE, Va., April 1, 2013 /PRNewswire/ -- Adenosine Therapeutics, LLC, a drug discovery and development company founded in 1999, announced today that it has engaged Needham & Company to explore strategic options for Stedivaze®, a highly selective adenosine A2A agonist being developed as a pharmacological stress agent for use in Myocardial Perfusion Imaging.

"We are seeking regional or global collaborators to rapidly conclude our Phase 3 clinical trials, which are more than halfway complete, and to pursue the approval, distribution, and marketing of Stedivaze®," said Adenosine Therapeutics Co-Founder and CEO Robert Capon . "Clinical trial data to date suggests Stedivaze® has the potential to demonstrate equivalent efficacy, compared to the standard of care, plus best-in-class product attributes, with the potential to expand the market for Cardiac Stress Agents."

"Stedivaze® has a strong patent estate with a long life," continued Robert Capon , "The pharmacological stress agent market is established, large (presently over $700 million in the United States), and growing. We believe that, with its potential best-in-class product characteristics, strong patent estate, and a large and growing market, that Stedivaze® represents an exceptional opportunity for the right partner. We are pleased to be working with Needham and Company to find such partner for this late-stage Specialty Pharma opportunity."

Adenosine Therapeutics, LLC is a drug discovery and development company founded in 1999. Adenosine Therapeutics holds the exclusive, worldwide license to the investigational compound apadenoson, the active pharmaceutical ingredient of Stedivaze®. The company re-acquired the exclusive, worldwide license to Stedivaze® on December 31, 2012. Two Phase 3 clinical trials for Stedivaze® are
'/>"/>

SOURCE Adenosine Therapeutics, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 According to a ... Identification (RFID) Market (Tags, Readers, Middleware, Printers and Cabinets) ... Forecast, 2014 - 2020" the global radiofrequency identification (RFID) ... and is expected to grow at a CAGR of ... value of USD 5.3 billion in 2020. ...
(Date:8/28/2014)... Aug. 28, 2014  In recognition of the increased ... from the flu, pneumonia, shingles and other illnesses, ... declared September to be Senior Vaccination Month. Because ... is important that adults ages 65 years and ... CVS pharmacists and MinuteClinic nurse practitioners and physician ...
(Date:8/28/2014)... Aug. 28, 2014   Venaxis, Inc.  (Nasdaq:  APPY), ... obtaining FDA clearance for and commercializing its CE Marked ... aiding in identifying children, adolescent, and young adult patients ... for appendicitis, today announced it will present at three ... Annual Global Investment Conference being held in ...
Breaking Medicine Technology:Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3
... 26, 2011 In a ceremony today, the University ... Chinese Academy of Sciences (CAS) to develop a joint ... of collaborative research and education in neuroimaging. ... Academy of Sciences Vice President Li Jiayang signed an ...
... 26, 2011 Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX ... overview at the Jefferies 2011 Global Healthcare Conference on June ... The live and archived webcast of the company ... Idenix Investor Center at www.idenix.com . Please log in ...
Cached Medicine Technology:University of Pennsylvania Announces Partnership with Chinese Academy of Sciences for Center of Excellence in Brain Mapping 2
(Date:8/28/2014)... Lack of sleep not only puts teens at risk for ... obesity, researchers warn. The study authors analyzed data collected ... and 21. Nearly one-fifth of them got less than six ... and this group was 20 percent more likely to be ... eight hours of sleep per night at age 16, the ...
(Date:8/28/2014)... they fall from trees and learn to flap their forelimbs ... and pump their "arms" to get aloft? , The answer ... new University of California, Berkeley, study provides a new piece ... in midair, a talent that could have helped their ancestors ... The study looked at how baby birds, in this case ...
(Date:8/28/2014)... NJ Top Docs Presents Dr. Christophe ... NJ Top Doc, Dr. Christophe Oliveira, has just ... examiner for the department of transportation. Dr. Oliveira ... perform all drug testing for commercial drivers. , ... musculoskeletal disorders including disk herniations, spinal stenosis, muscle ...
(Date:8/28/2014)... 2014 (BRONX, NY) Researchers from Albert Einstein ... have developed a potential antibody therapy for Sudan ebolavirus (SUDV), ... different strain, the Zaire ebolavirus (EBOV), is now devastating West ... Ebola outbreaks (most recently in 2012) that have killed ... in ACS Chemical Biology . , Between 30 ...
(Date:8/28/2014)... In 2012, The Ben & Catherine Ivy ... groundbreaking brain cancer research projects at the Translational ... has officially received the final regulatory approval from ... enrollment for the trial can begin. , In ... Glioblastoma Trial," TGen and its clinical partners will ...
Breaking Medicine News(10 mins):Health News:Less Sleep in Teen Years Tied to More Pounds at 21 2Health News:Flapping baby birds give clues to origin of flight 2Health News:Flapping baby birds give clues to origin of flight 3Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 3Health News:Drug shows promise against Sudan strain of Ebola in mice 2Health News:TGen receives approval for patient enrollment in brain cancer clinical trial 2
... New Delhi – This is good news for the families ... products. ,India’s drive to discourage people from ... all cigarette packets will include graphic descriptions of inherent health ... and mouth cancers will be displayed on the packs. Poignant ...
... Health (MoH), United Arab Emirates has revealed 645 cases of ... reported Wednesday. ,"Only a few cases were reported ... Ali Shukur, Under-secretary of the Ministry of Health was quoted ... attached to the fatal transmissible disorder was impeding to collect ...
... would soon be launching a major initiative to reduce ... it has been announced. ,Under the scheme ... (IMNCI), health volunteers, along with doctors and nurses, will ... a senior Health Ministry official. ,Under the ...
... “Withdrawal symptoms related to smoking can be better handled with ... the medical// journal Addiction. ,Dr. Adrian Taylor from ... study revealed that moderate exercise certainly had a better effect ... added that if the same effect was found in a ...
... an enviable reputation in the Malayalam movie industry, has decided ... heart- AIDS. Mohanlal will be the goodwill ambassador for the ... where five HIV+ve children in Kottayam district were forced to ... other children, the contribution by the actor will seek to ...
... held at Prague on Tuesday, the World Health Organization ... combat the movement of fake drugs especially in developing ... health technology, told that sale of spurious drugs in ... 25% of the total drug sales. He said that ...
Cached Medicine News:
... Holter, a full disclosure tape ... ECG analysis and unsurpassed,performance in ... use Windows 2000,XP and the ... option of employing,Advanced Biosensors,state-of-the-art,AB-180R digital ...
Universal Hub with Varying Blade Edge Diameters For Mounting the Blade to the Handle; Stainless Steel....
Blunt Tapered Tip in stainless steel....
... Signature Series multipurpose gamma camera is designed ... The system uniquely combines the high-energy and ... flexibility of modern day SPECT and planar ... maximizes camera performance in PET ...
Medicine Products: